Successful Pregnancy Outcome in a Patient with Juvenile Idiopathic Arthritis in Adulthood, Amyloid A Amyloidosis, and Chronic Kidney Disease Using Tocilizumab with Strict Blood Pressure Control
Pregnancies with chronic kidney disease (CKD) and high disease activity in rheumatic diseases are high-risk events with adverse outcomes for both the mother and fetus. We herein report a 35-year-old woman with juvenile idiopathic arthritis (JIA), amyloid A (AA) amyloidosis related to JIA, and CKD stage G4A2 who wished to have children. She achieved a successful pregnancy, even in the presence of these multiple risk factors, using tocilizumab to control the disease activity of JIA and AA amyloidosis, along with antihypertensive drugs to control her blood pressure before and during pregnancy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Internal medicine (Tokyo, Japan) - (2023) vom: 29. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Akira, Taro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amyloid A amyloidosis |
|---|
| Anmerkungen: |
Date Revised 01.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2169/internalmedicine.1951-23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362749515 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362749515 | ||
| 003 | DE-627 | ||
| 005 | 20231226091906.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2169/internalmedicine.1951-23 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM362749515 | ||
| 035 | |a (NLM)37779073 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Akira, Taro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successful Pregnancy Outcome in a Patient with Juvenile Idiopathic Arthritis in Adulthood, Amyloid A Amyloidosis, and Chronic Kidney Disease Using Tocilizumab with Strict Blood Pressure Control |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Pregnancies with chronic kidney disease (CKD) and high disease activity in rheumatic diseases are high-risk events with adverse outcomes for both the mother and fetus. We herein report a 35-year-old woman with juvenile idiopathic arthritis (JIA), amyloid A (AA) amyloidosis related to JIA, and CKD stage G4A2 who wished to have children. She achieved a successful pregnancy, even in the presence of these multiple risk factors, using tocilizumab to control the disease activity of JIA and AA amyloidosis, along with antihypertensive drugs to control her blood pressure before and during pregnancy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Juvenile idiopathic arthritis | |
| 650 | 4 | |a amyloid A amyloidosis | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a rheumatic diseases | |
| 650 | 4 | |a tocilizumab | |
| 700 | 1 | |a Shimazu, Yukiko |e verfasserin |4 aut | |
| 700 | 1 | |a Hashimoto, Nobuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Okushima, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Takehiro |e verfasserin |4 aut | |
| 700 | 1 | |a Tada, Tomomi |e verfasserin |4 aut | |
| 700 | 1 | |a Ikoma, Makiko |e verfasserin |4 aut | |
| 700 | 1 | |a Hosokawa, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Ueda, Yoshiyasu |e verfasserin |4 aut | |
| 700 | 1 | |a Takemura, Masahiko |e verfasserin |4 aut | |
| 700 | 1 | |a Fujiwara, Hiroshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g (2023) vom: 29. Sept. |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:29 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.1951-23 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 29 |c 09 | ||